$1.56
0.96% today
Nasdaq, Apr 04, 08:48 pm CET
ISIN
US68375N1037
Symbol
OPK
Sector
Industry

OPKO Health, Inc. Stock price

$1.57
-0.18 10.29% 1M
+0.06 3.97% 6M
+0.10 6.80% YTD
+0.22 16.30% 1Y
-2.04 56.51% 3Y
+0.41 35.34% 5Y
-12.76 89.04% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-0.08 4.85%
ISIN
US68375N1037
Symbol
OPK
Sector
Industry

Key metrics

Market capitalization $1.05b
Enterprise Value $1.13b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.58
P/S ratio (TTM) P/S ratio 1.48
P/B ratio (TTM) P/B ratio 0.77
Revenue growth (TTM) Revenue growth -17.42%
Revenue (TTM) Revenue $713.10m
EBIT (operating result TTM) EBIT $-273.52m
Free Cash Flow (TTM) Free Cash Flow $-208.50m
Cash position $431.94m
EPS (TTM) EPS $-0.09
P/E forward negative
P/S forward 1.59
EV/Sales forward 1.70
Short interest 32.29%
Show more

Is OPKO Health, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

OPKO Health, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a OPKO Health, Inc. forecast:

6x Buy
100%

Analyst Opinions

6 Analysts have issued a OPKO Health, Inc. forecast:

Buy
100%

Financial data from OPKO Health, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
713 713
17% 17%
100%
- Direct Costs 577 577
9% 9%
81%
136 136
41% 41%
19%
- Selling and Administrative Expenses 206 206
5% 5%
29%
- Research and Development Expense 105 105
17% 17%
15%
-175 -175
231% 231%
-25%
- Depreciation and Amortization 98 98
7% 7%
14%
EBIT (Operating Income) EBIT -274 -274
73% 73%
-38%
Net Profit -53 -53
72% 72%
-7%

In millions USD.

Don't miss a Thing! We will send you all news about OPKO Health, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OPKO Health, Inc. Stock News

Neutral
GlobeNewsWire
about 7 hours ago
MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company's existing common stock repurchase program, bringing the aggregate capacity of the program to $200 million. Approximately $41 million of OPKO's common stock has been repurchased under the existing program since its author...
Positive
Reuters
18 days ago
OPKO Health and Entera Bio are partnering to develop a once-daily pill for patients with obesity and other disorders, the companies said on Monday.
Neutral
PRNewsWire
24 days ago
Transaction to extend Labcorp's leadership in oncology and expand access to the company's high-quality clinical laboratory services BURLINGTON, N.C. and MIAMI , March 11, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that...
More OPKO Health, Inc. News

Company Profile

OPKO Health, Inc. engages in the provision of healthcare services. It operates through the following segments: Diagnostics, Pharmaceuticals, and Corporate. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Head office United States
CEO Phillip Frost
Employees 2,997
Founded 1991
Website www.opko.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today